A new trading day began on Tuesday, with Geron Corp (NASDAQ: GERN) stock price down -4.17% from the previous day of trading, before settling in for the closing price of $1.2. GERN’s price has ranged from $1.09 to $4.50 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 5.60% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 57.31%. With a float of $604.35 million, this company’s outstanding shares have now reached $637.85 million.
In an organization with 229 employees, it is important to assess its efficiency.
Geron Corp (GERN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 5.28%, while institutional ownership is 76.84%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.31% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Here are Geron Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.05 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Let’s dig in a bit further. During the last 5-days, its volume was 7.52 million. That was inferior than the volume of 11.23 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 28.75%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 12.24%, which indicates a significant increase from 5.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0586 in the past 14 days, which was lower than the 0.0766 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3104, while its 200-day Moving Average is $1.5789. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.2000. Second resistance stands at $1.2500. The third major resistance level sits at $1.2800. If the price goes on to break the first support level at $1.1200, it is likely to go to the next support level at $1.0900. The third support level lies at $1.0400 if the price breaches the second support level.
Geron Corp (NASDAQ: GERN) Key Stats
With a market capitalization of 733.72 million, the company has a total of 638,017K Shares Outstanding. Currently, annual sales are 76,990 K while annual income is -174,570 K. The company’s previous quarter sales were 49,040 K while its latest quarter income was -16,380 K.
